
#Expert advice
Generic drug supply at risk: global disruptions threaten Europe and Switzerland
Restrictions in the Strait of Hormuz have stalled the production of generics – which could have knock-on effects for global health and the Swiss export industry. With the chemical and pharmaceutical sector accounting for 53 per cent of total exports, Switzerland is particularly vulnerable.








